Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1
Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Lixoft division, a leading

QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine

NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Reports Inducement Grants Under Nasdaq Listing Rules


NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity

Humana Healthy Horizons Recommended by Indiana Family and Social Services Administration to Serve Medicaid Beneficiaries
Humana Healthy Horizons Recommended by Indiana Family and Social Services Administration to Serve Medicaid Beneficiaries


Leading integrated health and wellness company Humana Inc. (NYSE: HUM) has been notified by the Indiana Family and Social Services Administration (FSSA) that FSSA is recommending Humana be awarded

Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum
Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual

Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine: https://unsplash.com/photos/WUehAgqO5hE
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine


Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system

Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference
Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting

Premier Inc. to Participate in Barclays Global Healthcare Conference on March 14, 2023
Premier Inc. to Participate in Barclays Global Healthcare Conference on March 14, 2023


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Barclays

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Agilent to Present at Barclays Global Healthcare Conference
Agilent to Present at Barclays Global Healthcare Conference


Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida

EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

Acadia Healthcare to Participate in March Investor Conferences
Acadia Healthcare to Participate in March Investor Conferences


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in March.



On Tuesday, March 7, 2023, the Company will participate in

Humana and Aledade Announce 10 Year Collaboration
Humana and Aledade Announce 10 Year Collaboration


Aledade, the nation’s largest network of independent primary care, and Humana Inc. (NYSE: HUM), leading health insurer and health care services company, have announced a 10-year collaboration to

Agilent Reports First-Quarter Fiscal Year 2023 Financial Results:
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a

Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting

Acadia Healthcare Reports Fourth Quarter 2022 Results
Acadia Healthcare Reports Fourth Quarter 2022 Results


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2022.



Fourth Quarter Highlights




  • Revenue totaled $675.3

Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler


Agilent Technologies Inc. (NYSE: A) today announced the release of an on-deck thermal cycler (ODTC) that integrates with the Agilent Bravo NGS automated liquid handling platform. The optional ODTC

Inogen Announces Fourth Quarter and Full Year 2022 Financial Results
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the

Inogen to Provide Strategy Update on February 27, 2023
Inogen to Provide Strategy Update on February 27, 2023


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday

Dexcom Announces Upcoming Conference Presentations
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:




  • Sean Christensen, Vice President, Finance and

Dexcom Announces Upcoming Conference Presentations
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:




  • Sean Christensen, Vice President, Finance and

Agilent Announces Cash Dividend of 22.5 Cents Per Share
Agilent Announces Cash Dividend of 22.5 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of